|Articles|November 2, 2014

Pharmaceutical Technology

  • Pharmaceutical Technology-11-02-2014
  • Volume 38
  • Issue 11

Steritest Symbio Pumps Increase Productivity

EMD Millipore's Steritest Symbio Pumps are designed to create more reliable sterility testing in laminar flow hoods, isolators, and clean rooms.

EMD Millipore’s Steritest Symbio Pumps are designed to create more reliable sterility testing in laminar flow hoods, isolators, and clean rooms. Designed to address pharmaceutical testing requirements, the ergonomic pumps feature a compact housing design for easier access in laminar flow hoods, more compatibility with vertical and horizontal air flows, increased working space, an increased loading capacity in isolators, a drain tray designed to minimize splashing under the canister base, and adjustable positioning of the bottle holder.

The gas decontamination-resistant pump head allows quick introduction of filtration units, and the automatic closure provides repeatable tubing placement. The pumps are equipped with a timer function that allows small volumes to be accurately sampled, and the test methods library stores up to 250 filtration protocols ensuring reproducibility and efficiency.

EMD Milliporewww.emdmillipore.com

Articles in this issue


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.